niclosamide has been researched along with Congenital Zika Syndrome in 5 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we screened a small library of niclosamide derivatives and identified a new analogue with improved pharmacokinetic properties." | 5.56 | JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both ( Butler, D; Chen, H; D'Brant, L; Fan, X; Hu, S; Koetzner, CA; Kramer, LD; Kuo, L; Lang, Y; Li, H; Li, Z; Rugenstein, N; Samrat, SK; Tharappel, AM; Trudeau, N; Xu, J; Zhang, J; Zhang, QY; Zhou, J, 2020) |
" Here, we screened a small library of niclosamide derivatives and identified a new analogue with improved pharmacokinetic properties." | 1.56 | JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both ( Butler, D; Chen, H; D'Brant, L; Fan, X; Hu, S; Koetzner, CA; Kramer, LD; Kuo, L; Lang, Y; Li, H; Li, Z; Rugenstein, N; Samrat, SK; Tharappel, AM; Trudeau, N; Xu, J; Zhang, J; Zhang, QY; Zhou, J, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM | 1 |
Yasgar, A | 1 |
Teramoto, T | 1 |
Lee, MH | 1 |
Dorjsuren, D | 1 |
Eastman, RT | 1 |
Malik, N | 1 |
Zakharov, AV | 1 |
Li, W | 1 |
Bachani, M | 1 |
Brimacombe, K | 1 |
Steiner, JP | 1 |
Hall, MD | 1 |
Balasubramanian, A | 1 |
Jadhav, A | 1 |
Padmanabhan, R | 1 |
Simeonov, A | 2 |
Nath, A | 1 |
Yang, W | 1 |
Liu, LB | 1 |
Liu, FL | 1 |
Wu, YH | 1 |
Zhen, ZD | 1 |
Fan, DY | 1 |
Sheng, ZY | 1 |
Song, ZR | 1 |
Chang, JT | 1 |
Zheng, YT | 1 |
An, J | 1 |
Wang, PG | 1 |
Huang, Y | 1 |
Li, Q | 1 |
Kang, L | 1 |
Li, B | 1 |
Ye, H | 1 |
Duan, X | 1 |
Xie, H | 1 |
Jiang, M | 1 |
Li, S | 1 |
Zhu, Y | 1 |
Tan, Q | 1 |
Chen, L | 1 |
Li, Z | 1 |
Xu, J | 1 |
Lang, Y | 1 |
Fan, X | 1 |
Kuo, L | 1 |
D'Brant, L | 1 |
Hu, S | 1 |
Samrat, SK | 1 |
Trudeau, N | 1 |
Tharappel, AM | 1 |
Rugenstein, N | 1 |
Koetzner, CA | 1 |
Zhang, J | 1 |
Chen, H | 1 |
Kramer, LD | 1 |
Butler, D | 1 |
Zhang, QY | 1 |
Zhou, J | 1 |
Li, H | 1 |
Xu, M | 1 |
Lee, EM | 1 |
Wen, Z | 1 |
Cheng, Y | 1 |
Huang, WK | 1 |
Qian, X | 1 |
Tcw, J | 1 |
Kouznetsova, J | 1 |
Ogden, SC | 1 |
Hammack, C | 1 |
Jacob, F | 1 |
Nguyen, HN | 1 |
Itkin, M | 1 |
Hanna, C | 1 |
Shinn, P | 1 |
Allen, C | 1 |
Michael, SG | 1 |
Huang, W | 1 |
Christian, KM | 1 |
Goate, A | 1 |
Brennand, KJ | 1 |
Huang, R | 1 |
Xia, M | 1 |
Ming, GL | 1 |
Zheng, W | 1 |
Song, H | 1 |
Tang, H | 1 |
5 other studies available for niclosamide and Congenital Zika Syndrome
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation.
Topics: Animals; Complement Activation; Male; Mice; Niclosamide; Sequence Analysis, RNA; Zika Virus; Zika Vi | 2023 |
Mitophagy Activation Targeting PINK1 Is an Effective Treatment to Inhibit Zika Virus Replication.
Topics: Animals; Mice; Mitophagy; Niclosamide; Protein Kinases; Ubiquitin; Zika Virus; Zika Virus Infection | 2023 |
JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both
Topics: Animals; Flavivirus; Humans; Niclosamide; Viral Nonstructural Proteins; Zika Virus; Zika Virus Infec | 2020 |
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.
Topics: Astrocytes; Brain; Caspase 3; Caspase Inhibitors; Cell Death; Cell Line; Drug Repositioning; Humans; | 2016 |